NCT00214058View on ClinicalTrials.gov

Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

February 28, 2006

Conditions

Ovarian CarcinomaPrimary Peritoneal Carcinoma

Interventions

DRUG

Carboplatin

DRUG

Docetaxel

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

University of Wisconsin, Madison

OTHER